By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Cleveland Clinic and Genzyme Will Pursue New Multiple Sclerosis Treatments
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Business > Finance > Cleveland Clinic and Genzyme Will Pursue New Multiple Sclerosis Treatments
BusinessFinanceMedical InnovationsPublic Health

Cleveland Clinic and Genzyme Will Pursue New Multiple Sclerosis Treatments

Deanna Pogorelc
Deanna Pogorelc
Share
2 Min Read
SHARE

multiple sclerosisFirst published on MedCityNews.com. In the latest pharma-academia partnership, Genzyme and Cleveland Clinic researchers will align their efforts to better understand and treat multiple sclerosis.

multiple sclerosisFirst published on MedCityNews.com. In the latest pharma-academia partnership, Genzyme and Cleveland Clinic researchers will align their efforts to better understand and treat multiple sclerosis.

Their new research collaboration will span at least five years and will be led by a steering committee of researchers from both organizations, Genzyme said. Initially, their work will focus on better understanding the pathology of MS and exploring new strategies for preventing and treating neurodegeneration associated with the disease.

As Big Pharma continues to expand its external R&D efforts, these kind of relationships with academic medical centers, which could benefit from eventual licensing agreements if their research is successful, have become somewhat commonplace. Gilead and Yale inked a multi-year collaboration to search for new targets for cancer therapies, for example. And through its Centers for Therapeutic Innovation, Pfizer is working with academics at about two-dozen institutions to develop drugs.

More Read

Straight Talk About Medical Malpractice Reform
Clinical Trial Recruitment Success Demands a Patient-First Approach
Where Will Medicine Be 20 Years from Now?
20 Rules to Kick-Start Successful Email Marketing
What Will You Pay for Insurance Under ObamaCare?

A Cleveland Clinic spokeswoman said the health system also has other similar research and development agreements with pharmaceutical companies.

Genzyme markets Aubagio, a once-daily oral drug for relapsing forms of MS, and said in the announcement it’s committed to building a “sustainable pipeline of novel therapeutic approaches.” But that took a blow in December when the FDA rejected its late-stage drug candidate Alemtuzumab (Lemtrada). Genzyme has said it will resubmit for approval this quarter.

At the early-stage end of the pipeline, Cleveland Clinic is a likely partner because its Mellen Center for Multiple Sclerosis sees 20,000 patients a year and has a “highly innovative and active research team,” Genzyme said.

The terms of the agreement were not disclosed.

TAGGED:cleveland clinicGenzymemultiple sclerosis
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

Traumatic Brain Injuries
Understanding Traumatic Brain Injuries: What Families Need to Know
Policy & Law
October 10, 2025
Remote Monitoring touchpoints
Remote Monitoring Touchpoints Patients Will Actually Follow
Technology
October 9, 2025
dental care
Importance of Good Dental Care for Health and Confidence
Dental health Specialties
October 2, 2025
AI in Healthcare
AI in Healthcare: Technology is Transforming the Global Landscape
Global Healthcare Policy & Law Technology
October 1, 2025

You Might also Like

Healthcare Reimbursement
BusinessFinanceHospital Administration

5 Trends in Healthcare Reimbursement

September 24, 2014

Post Holiday Blues: Who Will Pay for The Doc Pay Fix?

November 26, 2011
Hospital AdministrationMedical Education

How to Make More With Your Job in Nursing

December 16, 2017

Why Clinicians Are Frustrated with Health IT

February 19, 2015
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?